Previous Close | 13.73 |
Open | 13.79 |
Bid | 5.64 x 900 |
Ask | 22.54 x 1000 |
Day's Range | 13.56 - 14.24 |
52 Week Range | 13.36 - 39.67 |
Volume | |
Avg. Volume | 495,178 |
Market Cap | 512.846M |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for NVRO
Nevro's (NVRO) SI joint fusion device, Nevro1, gets FDA clearance for the use of a lateral screw NevroFix.
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.
Nevro Corp. (NYSE:NVRO) Q4 2023 Earnings Call Transcript February 21, 2024 Nevro Corp. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.5. Nevro Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Nevro’s Fourth […]